CXCL12-dependent modulation of tumor cell proliferation and survival (under suboptimal conditions) has been observed in several tumor types, including ovarian carcinoma[21], small cell lung cancer[22] and prostate cancer[23]. This evidence concerns the gene CXCL12 and ovarian carcinoma.